China on Tuesday added 148 drugs to its list of medicines covered by basic medical insurance schemes, part of a push to lower patients’ out-of-pocket costs in one of the world’s largest drug markets, state media reported. AstraZeneca’s Kombiglyze and …
from News – Insurance Journal
没有评论:
发表评论